Tag: BEAM-201

IND application for BEAM-201 suspended by FDA

ADC评论 August 3, 2022

On August 1, 2022, base editing company Beam Therapeutics announced that its IND application for BEAM-201 was suspended by the FDA. The FDA will provide

Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry

October 20, 2023

TCO-Functionalized PEG Derivatives: Versatile Tools for Bioconjugation

October 16, 2023

Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research

October 8, 2023

BCN Compounds in Pharmaceutical Research and Development

October 6, 2023

An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries

September 19, 2023

Unveiling the Power of Protein Conjugation: The Biochemical Game Changer

May 26, 2023

Tag: BEAM-201

IND application for BEAM-201 suspended by FDA

Latest Articles

Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry

TCO-Functionalized PEG Derivatives: Versatile Tools for Bioconjugation

Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research

BCN Compounds in Pharmaceutical Research and Development

An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries

Unveiling the Power of Protein Conjugation: The Biochemical Game Changer

Hot Articles

Info

Subcribe